B4GALNT1
Chr 12ARbeta-1,4-N-acetyl-galactosaminyltransferase 1
Also known as: GALGT, GALNACT, GalNAc-T, SPG26
The protein catalyzes the transfer of GalNAc to GM3 and GD3 gangliosides via beta-1,4 linkage to synthesize GM2 and GD2 gangliosides, functioning in the Golgi apparatus membrane. Mutations cause spastic paraplegia 26 through autosomal recessive inheritance. The pathogenic mechanism likely involves disrupted ganglioside biosynthesis leading to progressive spasticity of the lower limbs.
Definitive — sufficient evidence for diagnostic panels
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Typical tolerance to LoF variation
Mild missense constraint
ClinVar Variant Classifications
315 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 19 | 0 | 4 | 0 | 23 |
Likely Pathogenic | 11 | 2 | 2 | 0 | 15 |
VUS | 0 | 131 | 10 | 2 | 143 |
Likely Benign | 0 | 6 | 32 | 66 | 104 |
Benign | 0 | 2 | 18 | 2 | 22 |
Conflicting | — | 2 | |||
| Total | 30 | 141 | 66 | 70 | 309 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
B4GALNT1 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools